[HTML][HTML] BI 456906: discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy

T Zimmermann, L Thomas, T Baader-Pagler… - Molecular …, 2022 - Elsevier
Objective Obesity and its associated comorbidities represent a global health challenge with
a need for well-tolerated, effective, and mechanistically diverse pharmaceutical …

Estimating the global burden of Epstein–Barr virus-related cancers

Y Wong, MT Meehan, SR Burrows, DL Doolan… - Journal of Cancer …, 2022 - Springer
Background More than 90% of the adult population globally is chronically infected by the
Epstein–Barr virus (EBV). It is well established that EBV is associated with a number of …

The state of health in Indonesia's provinces, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

N Mboi, R Syailendrawati, SM Ostroff… - The Lancet Global …, 2022 - thelancet.com
Background Analysing trends and levels of the burden of disease at the national level can
mask inequalities in health-related progress in lower administrative units such as provinces …

Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study

GR Dagenais, DP Leong, S Rangarajan, F Lanas… - The Lancet, 2020 - thelancet.com
Background To our knowledge, no previous study has prospectively documented the
incidence of common diseases and related mortality in high-income countries (HICs), middle …

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

C Abbafati, DB Machado, B Cislaghi, OM Salman… - 2020 - dro.deakin.edu.au
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a
systematic analysis for the Glo Page 1 Global Health Metrics 1204 www.thelancet.com Vol 396 …

[HTML][HTML] Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference

AS Levey, KU Eckardt, NM Dorman, SL Christiansen… - Kidney international, 2020 - Elsevier
The worldwide burden of kidney disease is rising, but public awareness remains limited,
underscoring the need for more effective communication by stakeholders in the kidney …

Canadian stroke best practice recommendations: rehabilitation, recovery, and community participation following stroke. Part one: rehabilitation and recovery following …

R Teasell, NM Salbach, N Foley… - … Journal of Stroke, 2020 - journals.sagepub.com
The sixth update of the Canadian Stroke Best Practice Recommendations: Rehabilitation,
Recovery, and Reintegration following Stroke. Part one: Rehabilitation and Recovery …

Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017

L Dwyer-Lindgren, MA Cork, A Sligar, KM Steuben… - Nature, 2019 - nature.com
HIV/AIDS is a leading cause of disease burden in sub-Saharan Africa. Existing evidence has
demonstrated that there is substantial local variation in the prevalence of HIV; however …

Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic

A Dunlop, B Lokuge, D Masters, M Sequeira… - Harm reduction …, 2020 - Springer
The impact of COVID-19 across health services, including treatment services for people who
use drugs, is emerging but likely to have a high impact. Treatment services for people who …

Global patterns of opioid use and dependence: harms to populations, interventions, and future action

L Degenhardt, J Grebely, J Stone, M Hickman… - The Lancet, 2019 - thelancet.com
We summarise the evidence for medicinal uses of opioids, harms related to the extramedical
use of, and dependence on, these drugs, and a wide range of interventions used to address …